Abstract:Background Cellular cementum (CC) includes cementocytes, cells suspected to regulate CC formation or resorption as osteocytes do in bone. Sclerostin (SOST) is a secreted negative regulator of Wnt/β‐catenin signaling expressed by osteocytes and cementocytes. Osteocyte SOST expression reduces bone formation. We investigated the functional importance of SOST in CC compared with alveolar bone (AB) using a Sost knockout (Sost−/−) mouse model to better understand the role of cementocytes in CC. Methods Mandibles and femurs of Sost−/− and wild‐type (WT) mice were analyzed at 42 and 120 days postnatal (dpn). Maxillary first molars were bilaterally extracted at 42 dpn and both AB healing (maxillary molar sockets) and CC apposition (mandibular first molars) were examined at 21 days post‐procedure. Analyses included micro‐computed tomography, histology, and immunohistochemistry. Results Femur cortical and trabecular bone and mandibular bone volumes were similarly increased in Sost−/− versus WT mice at 42 and/or 120 dpn. In contrast to previous reports, CC was not increased by Sost−/− at either age. We conducted challenge experiments on AB and CC to explore tissue‐specific responses. Post‐extraction AB healing was improved by Sost deletion. In contrast, experimentally‐induced apposition in molars failed to stimulate increased CC formation in Sost−/− versus WT mice. Wnt pathway markers AXIN2 and DKK1, which were increased in Sost−/− versus WT AB osteocytes, were unchanged in cementocytes. Conclusions These data indicate CC is less responsive than AB to SOST deletion. Within the study limitations, these results do not support cementocytes as critical for directing increased CC formation. Plain language summary Sclerostin is a protein known to inhibit bone formation, and removing sclerostin leads to more bone formation. Cementum is the thin layer that covers the surface of the tooth's root. Previous studies suggest that inhibiting sclerostin can similarly increase the amount of cementum. We wanted to compare the response of cementum and bone when sclerostin is absent to understand similarities and differences between these two tissues. In this study, we removed the Sost gene (the gene which produces sclerostin) in mice. We found that mice without sclerostin have more bone in their legs and jaws. Moreover, mice without sclerostin also healed better after tooth removal compared with normal mice. Surprisingly, unlike previous studies, we found that the amount of cementum was not different in mice without sclerostin compared with normal mice. Additionally, we challenged the cementum by taking out the opposing tooth to cause the first mandibular molar to move up by building more cementum. Even with this challenge, we found no difference in the amount of cementum in mice lacking sclerostin compared with normal mice. Therefore, we conclude here that cementum is less sensitive to the absence of sclerostin compared with bone.

Effect of sclerostin on cementogenesis and its mechanism

Disparate effects of sclerostin deletion on alveolar bone and cellular cementum in mice

Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways

Molecular mechanism of sclerostin on bone remoldling

Sclerostin is a Promising Therapeutic Target for Oral Inflammation and Regenerative Dentistry

Effect of Cells Derived from Periodontal Ligament Tissue on Bone Formation

Sclerostin Inhibits Odontogenic Differentiation Of Human Pulp-Derived Odontoblast-Like Cells Under Mechanical Stress

Sclerostin and skeletal health

Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells

Effects of sclerostin on lipopolysaccharide-induced inflammatory phenotype in human odontoblasts and dental pulp cells.

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein

Sclerostin Protects Against Vascular Calcification Development in Mice

Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis

Sclerostin Regulation: a Promising Therapy for Periodontitis by Modulating Alveolar Bone

Regulation of Osteoblast Differentiation by Osteocytes Cultured on Sclerostin Antibody Conjugated TiO2 Nanotube Array.

Sclerostin inhibits Protein kinase C inhibitor GÖ6976 induced osteogenic differentiation of dental follicle cells

Connective Tissue Growth Factor Promotes Cementogenesis and Cementum Repair Via Cx43/β-catenin Axis

Intermittent Parathyroid Hormone (pth) Promotes Cementogenesis and Alleviates the Catabolic Effects of Mechanical Strain in Cementoblasts

Sclerostin modulates mineralization degree and stiffness profile in the fibrocartilaginous enthesis for mechanical tissue integrity

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.